Phase I combination dose-finding/phase II expansion cohorts of lenvatinib + etoposide + ifosfamide in patients (pts) aged 2 to ≤ 25 years with relapsed/refractory (r/r) osteosarcoma
Year: 2019
Type: article
Source: Annals of Oncology
Authors: N. Gaspar, F J Bautista Sirvent, R. Venkatramani, A. Longhi, C. Lervat, M. Casanova, I. Aerts, S.S. Bielack, N. Entz-Werle, S. Strauss, C. He, E. Thebaud, F. Locatelli, B. Morland, S Gallego Melcon, A Cañete Nieto, P. Marec- Bérard, M. Gambart, C. Rossig, Q. Campbell-Hewson
Institutions: Institut Gustave Roussy, Fondation Gustave Roussy, Hospital Infantil Universitario Niño Jesús, Texas Children's Hospital, Istituto Ortopedico Rizzoli, Centre Oscar Lambret, Fondazione IRCCS Istituto Nazionale dei Tumori, Université Paris Sciences et Lettres, Institut Curie, Olgahospital, Klinikum Stuttgart, Hôpital d'Hautepierre, University College Hospital, University College London Hospitals NHS Foundation Trust, Eisai (United States), Centre Hospitalier Universitaire de Nantes, Hôpital Mère-Enfant, University of Pavia, Bambino Gesù Children's Hospital, Birmingham Children's Hospital, Vall d'Hebron Hospital Universitari, Hospital Universitari i Politècnic La Fe, Centre Léon Bérard, Centre Hospitalier Universitaire de Toulouse, Hôpital des Enfants, University of Münster, University Hospital Münster, Royal Victoria Infirmary, Great North Children's Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2977922663
